nne

Calcium channel-modulator-1是钙离子通道调节剂(IC50:0.8 μM)，具有阻塞主动脉收缩的专业化。

Calcium Channel antagonist 4 是一种电压门控钙通道抑制剂（IC50 : 5-20μM）。

Calcium Channel antagonist 3 是一种电压门控钙通道抑制剂（IC50 : 5-20μM）。

Ca2+channel agonist 1 是 N-型钙离子通道激动剂和Cdk2的抑制剂，EC50分别为 14.23 μM 和 3.34 μM，可用作运动神经末梢功能障碍的潜在治疗方法。

Potassium Channel Activator 1 可用于治疗多巴胺能系统被破坏的疾病或病症的研究，例如情绪障碍 ADHD、精神分裂症和其他精神病状态。

M2 ion channel blocker ,Antiviral agent, is capable of inhibiting and blocking the activity of M2 ion channel.

Minnelide 是水溶性雷公藤内酯前药，具有抗癌症抗肿瘤活性，可诱导细胞凋亡，可预防足细胞损伤。Minnelide 通过阻断 HPV 诱导的 p53 和 pRb 变化来抑制宫颈癌的生长。

N-type calcium channel blocker-1 is an orally active analgesic agent,shows high affinity to functionally block N-type calcium channels.

Sodium Channel inhibitor1 is a novel and selective voltage-gated sodium channel for pain treatment. (IC50 Value of 0.16 uM and 0.41 uM for Na v1.7, V hold-90mV and Na v1.7, V hold-90mV)

Sodium Channel inhibitor 2 is a blocker of sodium channel.

Calcium Channel antagonist5 (compound 32) 是一种钙通道拮抗剂，pIC50为5.50。

Sodium Channel inhibitor6 (compound I) 是用于神经性疼痛研究的钠通道 (sodium channel) 抑制剂。

Ceftaroline fosamil (TAK-599) inner salt, a cephalosporin derivative, is an N-phosphono prodrug of anti-methicillin-resistant Staphylococcus aureus (MRSA) T-91825. Ceftaroline fosamil inner salt can be used for the research of MRSA infection.

KCa2 channel modulator 1 (compound 2o) 是有效的亚型选择性的K Ca 通道的正调节剂，其增强大鼠 KCa2.2 通道亚型的EC50值为 0.99 μM 和人KCa2.3 通道亚型的EC50值为 0.19 μM。

KCa2 channel modulator 2 (compound 2q) 是有效的亚型选择性KCa2通道的正调节剂，对人KCa2.3 通道和大鼠 KCa2.2 通道亚型显示出相似的效力，EC50值分别为 0.6 μM 和 0.64 μM。

SK3 Channel-IN-1 (compound 7a) is a powerful and selective modulator of the SK3 channel. It demonstrates significant efficacy in inhibiting breast cancer MDA-MB-435 cell migration while maintaining low cytotoxicity in other cell lines. Furthermore, SK3 Channel-IN-1 exhibits the ability to modulate ion channel activity in cancer cells [1].

T-Type calcium channel inhibitor 2 (compound 6g) 是一种 T 型钙通道的有效抑制剂，能够作用于 Cav3.1 (α1G) (IC50: 31.0 μM)、Cav3.2 (α1H) (IC50: 83.1 μM)、Cav3.3 (α1I) (α1H) (IC50: 69.3 μM)。T-Type calcium channel inhibitor 2 对 A549、HCT-116 细胞表现出细胞毒性，IC50s 分别为5.0、6.4 μM。

(Methoxycarbonylsulfamoyl)triethylammonium hydroxide, inner salt 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T65053，CAS号为 29684-56-8。

Minnelide is an effective therapy against pancreatic cancer. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants. Minnelide reduced tumor volume in multiple models of pancreatic cancer. Minnelide was a more effective drug against pancreatic cancer models. It effectively reduced tumor burden and tumor related morbidity in different unique but complementary mouse models. It reduced metastatic spread and increased survival in the different models as well.

NaV1.2 1.6 channel blocker-1 是一种有效的 NaV1.2 1.6 channel 阻滞剂，对 rNaV1.6 和 hNaV1.2 有抑制作用。NaV1.2 1.6 channel blocker-1 可用于研究全身性癫痫和运动障碍。

KCa1.1 channel activator-1 (化合物 1E) 是一种槲皮素衍生物，是选择性的血管 KCa1.1 channel 刺激剂。KCa1.1 channel activator-1 也显示 CaV1.2 channel 通道阻断活性。KCa1.1 channel activator-1 表现出较弱的肌肉松弛活性。

KCa1.1 channel activator-2 (化合物 3F) 是一种槲皮素衍生物，是选择性的血管 KCa1.1 channel 刺激剂。KCa1.1 channel activator-2 具有强效的肌肉松弛活性。

Calcium Channel antagonist 2是一种 calcium channel 拮抗剂 (IC50=5-20 μM)，可用于研究像疼痛和糖尿病等由于 Ca2+ 通道造成的疾病。

Nav1.3 channel inhibitor 1 (化合物 15b) 为状态依赖性电压门控钠通道Nav1.3的抑制剂，具有IC50值为20 nM。该化合物能穿透血脑屏障，适用于神经系统疾病研究。